- Clinical Trials
- April 2025
- 60 Pages
Global
From €1869EUR$2,000USD£1,561GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1168EUR$1,250USD£976GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1168EUR$1,250USD£976GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1869EUR$2,000USD£1,561GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1402EUR$1,500USD£1,171GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1168EUR$1,250USD£976GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1869EUR$2,000USD£1,561GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1402EUR$1,500USD£1,171GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1402EUR$1,500USD£1,171GBP
- Report
- June 2024
- 200 Pages
Global
From €7428EUR$7,950USD£6,206GBP
- Report
- July 2025
- 350 Pages
Global
From €4624EUR$4,949USD£3,863GBP
- Report
- June 2025
- 200 Pages
Global
From €2606EUR$2,789USD£2,177GBP
- Report
- July 2024
- 162 Pages
Africa
From €2336EUR$2,500USD£1,951GBP
- Report
- July 2024
- 164 Pages
Global
From €2336EUR$2,500USD£1,951GBP
- Report
- May 2024
- 134 Pages
Global
From €3737EUR$3,999USD£3,122GBP
- Report
- December 2023
- 221 Pages
Global
From €3363EUR$3,599USD£2,809GBP
- Report
- May 2025
- 134 Pages
Global
From €16814EUR$17,995USD£14,047GBP
- Report
- December 2024
- 59 Pages
Global
From €3733EUR$3,995USD£3,118GBP
- Report
- August 2025
- 150 Pages
Global
From €4532EUR$4,850USD£3,786GBP
- Report
- July 2025
- 150 Pages
Global
From €4532EUR$4,850USD£3,786GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more